Key result
Circulating CTRP9 levels are significantly lower in patients with CAD versus those without.
Why the study?
Studies have reported conflicting results regarding circulating CTRP9 levels in patients with and without coronary artery disease.
Are circulating CTRP9 levels associated with coronary artery disease?
Population
Patients across 25 included articles
Comparison
CAD patients vs patients without CAD
Design
Systematic review and meta-analysis
Authors
Loading...
May support CTRP9 as CAD biomarker; hypothesis-generating and needs prospective validation before clinical adoption.
Meta-Analysis
Are circulating CTRP9 levels associated with coronary artery disease?
p-value: p== 0.001
Circulating CTRP9 levels are significantly lower in patients with coronary artery disease compared to those without, suggesting a potential role as a biomarker.
Zhu et al. (2024) conducted a meta-analysis in Coronary artery disease. Circulating CTRP9 levels vs. Patients without CAD was evaluated on Circulating CTRP9 levels (p== 0.001). Circulating CTRP9 levels in patients with coronary artery disease were significantly lower than those in patients without CAD (P=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: